Global Hospital-Acquired Disease Testing Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Hospital-Acquired Disease Testing market size was valued at US$ 481.5 million in 2023. With growing demand in downstream market, the Hospital-Acquired Disease Testing is forecast to a readjusted size of US$ 695.6 million by 2030 with a CAGR of 5.4% during review period.
The research report highlights the growth potential of the global Hospital-Acquired Disease Testing market. Hospital-Acquired Disease Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Hospital-Acquired Disease Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Hospital-Acquired Disease Testing market.
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Hospital-Acquired Disease Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Hospital-Acquired Disease Testing market. It may include historical data, market segmentation by Type (e.g., UTI Testing, SSI Testing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Hospital-Acquired Disease Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Hospital-Acquired Disease Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Hospital-Acquired Disease Testing industry. This include advancements in Hospital-Acquired Disease Testing technology, Hospital-Acquired Disease Testing new entrants, Hospital-Acquired Disease Testing new investment, and other innovations that are shaping the future of Hospital-Acquired Disease Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Hospital-Acquired Disease Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Hospital-Acquired Disease Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Hospital-Acquired Disease Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Hospital-Acquired Disease Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Hospital-Acquired Disease Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Hospital-Acquired Disease Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Hospital-Acquired Disease Testing market.
Market Segmentation:
Hospital-Acquired Disease Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Hospital-Acquired Disease Testing market size was valued at US$ 481.5 million in 2023. With growing demand in downstream market, the Hospital-Acquired Disease Testing is forecast to a readjusted size of US$ 695.6 million by 2030 with a CAGR of 5.4% during review period.
The research report highlights the growth potential of the global Hospital-Acquired Disease Testing market. Hospital-Acquired Disease Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Hospital-Acquired Disease Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Hospital-Acquired Disease Testing market.
Hospital acquired infections/diseases (HAIs) or nosocomial infections are defined to the infection acquired by patients during their stay in healthcare settings. Approximately 9.2 out of 100 patients in the U.S. acquire HAI. The most common types of HAIs include pneumonia, urinary tract infection, bloodstream infection, surgical site infection and others. HAIs are caused by pathogens among patients with compromised immune system, and negligence by hospital staff. The significant morbidity and mortality, the associated management costs and growing pressure from governing bodies have urged care-givers to devise accurate diagnosis of HAIs for efficient healthcare provision.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Hospital-Acquired Disease Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Hospital-Acquired Disease Testing market. It may include historical data, market segmentation by Type (e.g., UTI Testing, SSI Testing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Hospital-Acquired Disease Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Hospital-Acquired Disease Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Hospital-Acquired Disease Testing industry. This include advancements in Hospital-Acquired Disease Testing technology, Hospital-Acquired Disease Testing new entrants, Hospital-Acquired Disease Testing new investment, and other innovations that are shaping the future of Hospital-Acquired Disease Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Hospital-Acquired Disease Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Hospital-Acquired Disease Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Hospital-Acquired Disease Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Hospital-Acquired Disease Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Hospital-Acquired Disease Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Hospital-Acquired Disease Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Hospital-Acquired Disease Testing market.
Market Segmentation:
Hospital-Acquired Disease Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- UTI Testing
- SSI Testing
- Pneumococcal Infections Testing
- Bloodstream Infections Testing
- MRSA Testing
- Small and Medium Sized Hospitals
- Large Sized Hospitals
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Diatherix Laboratories
- Gen-Probe
- Qiagen
- F. Hoffmann-La Roche
- Cepheid
- Life Technologies Corporation
- Meridian Biosciences
- Cantel Medical Corporation
- Nordion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hospital-Acquired Disease Testing Market Size 2019-2030
2.1.2 Hospital-Acquired Disease Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Hospital-Acquired Disease Testing Segment by Type
2.2.1 UTI Testing
2.2.2 SSI Testing
2.2.3 Pneumococcal Infections Testing
2.2.4 Bloodstream Infections Testing
2.2.5 MRSA Testing
2.3 Hospital-Acquired Disease Testing Market Size by Type
2.3.1 Hospital-Acquired Disease Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
2.4 Hospital-Acquired Disease Testing Segment by Application
2.4.1 Small and Medium Sized Hospitals
2.4.2 Large Sized Hospitals
2.5 Hospital-Acquired Disease Testing Market Size by Application
2.5.1 Hospital-Acquired Disease Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
3 HOSPITAL-ACQUIRED DISEASE TESTING MARKET SIZE BY PLAYER
3.1 Hospital-Acquired Disease Testing Market Size Market Share by Players
3.1.1 Global Hospital-Acquired Disease Testing Revenue by Players (2019-2024)
3.1.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Hospital-Acquired Disease Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED DISEASE TESTING BY REGIONS
4.1 Hospital-Acquired Disease Testing Market Size by Regions (2019-2024)
4.2 Americas Hospital-Acquired Disease Testing Market Size Growth (2019-2024)
4.3 APAC Hospital-Acquired Disease Testing Market Size Growth (2019-2024)
4.4 Europe Hospital-Acquired Disease Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Hospital-Acquired Disease Testing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
5.2 Americas Hospital-Acquired Disease Testing Market Size by Type (2019-2024)
5.3 Americas Hospital-Acquired Disease Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hospital-Acquired Disease Testing Market Size by Region (2019-2024)
6.2 APAC Hospital-Acquired Disease Testing Market Size by Type (2019-2024)
6.3 APAC Hospital-Acquired Disease Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hospital-Acquired Disease Testing by Country (2019-2024)
7.2 Europe Hospital-Acquired Disease Testing Market Size by Type (2019-2024)
7.3 Europe Hospital-Acquired Disease Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hospital-Acquired Disease Testing by Region (2019-2024)
8.2 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET FORECAST
10.1 Global Hospital-Acquired Disease Testing Forecast by Regions (2025-2030)
10.1.1 Global Hospital-Acquired Disease Testing Forecast by Regions (2025-2030)
10.1.2 Americas Hospital-Acquired Disease Testing Forecast
10.1.3 APAC Hospital-Acquired Disease Testing Forecast
10.1.4 Europe Hospital-Acquired Disease Testing Forecast
10.1.5 Middle East & Africa Hospital-Acquired Disease Testing Forecast
10.2 Americas Hospital-Acquired Disease Testing Forecast by Country (2025-2030)
10.2.1 United States Hospital-Acquired Disease Testing Market Forecast
10.2.2 Canada Hospital-Acquired Disease Testing Market Forecast
10.2.3 Mexico Hospital-Acquired Disease Testing Market Forecast
10.2.4 Brazil Hospital-Acquired Disease Testing Market Forecast
10.3 APAC Hospital-Acquired Disease Testing Forecast by Region (2025-2030)
10.3.1 China Hospital-Acquired Disease Testing Market Forecast
10.3.2 Japan Hospital-Acquired Disease Testing Market Forecast
10.3.3 Korea Hospital-Acquired Disease Testing Market Forecast
10.3.4 Southeast Asia Hospital-Acquired Disease Testing Market Forecast
10.3.5 India Hospital-Acquired Disease Testing Market Forecast
10.3.6 Australia Hospital-Acquired Disease Testing Market Forecast
10.4 Europe Hospital-Acquired Disease Testing Forecast by Country (2025-2030)
10.4.1 Germany Hospital-Acquired Disease Testing Market Forecast
10.4.2 France Hospital-Acquired Disease Testing Market Forecast
10.4.3 UK Hospital-Acquired Disease Testing Market Forecast
10.4.4 Italy Hospital-Acquired Disease Testing Market Forecast
10.4.5 Russia Hospital-Acquired Disease Testing Market Forecast
10.5 Middle East & Africa Hospital-Acquired Disease Testing Forecast by Region (2025-2030)
10.5.1 Egypt Hospital-Acquired Disease Testing Market Forecast
10.5.2 South Africa Hospital-Acquired Disease Testing Market Forecast
10.5.3 Israel Hospital-Acquired Disease Testing Market Forecast
10.5.4 Turkey Hospital-Acquired Disease Testing Market Forecast
10.5.5 GCC Countries Hospital-Acquired Disease Testing Market Forecast
10.6 Global Hospital-Acquired Disease Testing Forecast by Type (2025-2030)
10.7 Global Hospital-Acquired Disease Testing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Diatherix Laboratories
11.1.1 Diatherix Laboratories Company Information
11.1.2 Diatherix Laboratories Hospital-Acquired Disease Testing Product Offered
11.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Diatherix Laboratories Main Business Overview
11.1.5 Diatherix Laboratories Latest Developments
11.2 Gen-Probe
11.2.1 Gen-Probe Company Information
11.2.2 Gen-Probe Hospital-Acquired Disease Testing Product Offered
11.2.3 Gen-Probe Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Gen-Probe Main Business Overview
11.2.5 Gen-Probe Latest Developments
11.3 Qiagen
11.3.1 Qiagen Company Information
11.3.2 Qiagen Hospital-Acquired Disease Testing Product Offered
11.3.3 Qiagen Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Qiagen Main Business Overview
11.3.5 Qiagen Latest Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Information
11.4.2 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Offered
11.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 F. Hoffmann-La Roche Main Business Overview
11.4.5 F. Hoffmann-La Roche Latest Developments
11.5 Cepheid
11.5.1 Cepheid Company Information
11.5.2 Cepheid Hospital-Acquired Disease Testing Product Offered
11.5.3 Cepheid Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cepheid Main Business Overview
11.5.5 Cepheid Latest Developments
11.6 Life Technologies Corporation
11.6.1 Life Technologies Corporation Company Information
11.6.2 Life Technologies Corporation Hospital-Acquired Disease Testing Product Offered
11.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Life Technologies Corporation Main Business Overview
11.6.5 Life Technologies Corporation Latest Developments
11.7 Meridian Biosciences
11.7.1 Meridian Biosciences Company Information
11.7.2 Meridian Biosciences Hospital-Acquired Disease Testing Product Offered
11.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Meridian Biosciences Main Business Overview
11.7.5 Meridian Biosciences Latest Developments
11.8 Cantel Medical Corporation
11.8.1 Cantel Medical Corporation Company Information
11.8.2 Cantel Medical Corporation Hospital-Acquired Disease Testing Product Offered
11.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Cantel Medical Corporation Main Business Overview
11.8.5 Cantel Medical Corporation Latest Developments
11.9 Nordion
11.9.1 Nordion Company Information
11.9.2 Nordion Hospital-Acquired Disease Testing Product Offered
11.9.3 Nordion Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Nordion Main Business Overview
11.9.5 Nordion Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hospital-Acquired Disease Testing Market Size 2019-2030
2.1.2 Hospital-Acquired Disease Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Hospital-Acquired Disease Testing Segment by Type
2.2.1 UTI Testing
2.2.2 SSI Testing
2.2.3 Pneumococcal Infections Testing
2.2.4 Bloodstream Infections Testing
2.2.5 MRSA Testing
2.3 Hospital-Acquired Disease Testing Market Size by Type
2.3.1 Hospital-Acquired Disease Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
2.4 Hospital-Acquired Disease Testing Segment by Application
2.4.1 Small and Medium Sized Hospitals
2.4.2 Large Sized Hospitals
2.5 Hospital-Acquired Disease Testing Market Size by Application
2.5.1 Hospital-Acquired Disease Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
3 HOSPITAL-ACQUIRED DISEASE TESTING MARKET SIZE BY PLAYER
3.1 Hospital-Acquired Disease Testing Market Size Market Share by Players
3.1.1 Global Hospital-Acquired Disease Testing Revenue by Players (2019-2024)
3.1.2 Global Hospital-Acquired Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Hospital-Acquired Disease Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED DISEASE TESTING BY REGIONS
4.1 Hospital-Acquired Disease Testing Market Size by Regions (2019-2024)
4.2 Americas Hospital-Acquired Disease Testing Market Size Growth (2019-2024)
4.3 APAC Hospital-Acquired Disease Testing Market Size Growth (2019-2024)
4.4 Europe Hospital-Acquired Disease Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Hospital-Acquired Disease Testing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Hospital-Acquired Disease Testing Market Size by Country (2019-2024)
5.2 Americas Hospital-Acquired Disease Testing Market Size by Type (2019-2024)
5.3 Americas Hospital-Acquired Disease Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hospital-Acquired Disease Testing Market Size by Region (2019-2024)
6.2 APAC Hospital-Acquired Disease Testing Market Size by Type (2019-2024)
6.3 APAC Hospital-Acquired Disease Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hospital-Acquired Disease Testing by Country (2019-2024)
7.2 Europe Hospital-Acquired Disease Testing Market Size by Type (2019-2024)
7.3 Europe Hospital-Acquired Disease Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hospital-Acquired Disease Testing by Region (2019-2024)
8.2 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Hospital-Acquired Disease Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HOSPITAL-ACQUIRED DISEASE TESTING MARKET FORECAST
10.1 Global Hospital-Acquired Disease Testing Forecast by Regions (2025-2030)
10.1.1 Global Hospital-Acquired Disease Testing Forecast by Regions (2025-2030)
10.1.2 Americas Hospital-Acquired Disease Testing Forecast
10.1.3 APAC Hospital-Acquired Disease Testing Forecast
10.1.4 Europe Hospital-Acquired Disease Testing Forecast
10.1.5 Middle East & Africa Hospital-Acquired Disease Testing Forecast
10.2 Americas Hospital-Acquired Disease Testing Forecast by Country (2025-2030)
10.2.1 United States Hospital-Acquired Disease Testing Market Forecast
10.2.2 Canada Hospital-Acquired Disease Testing Market Forecast
10.2.3 Mexico Hospital-Acquired Disease Testing Market Forecast
10.2.4 Brazil Hospital-Acquired Disease Testing Market Forecast
10.3 APAC Hospital-Acquired Disease Testing Forecast by Region (2025-2030)
10.3.1 China Hospital-Acquired Disease Testing Market Forecast
10.3.2 Japan Hospital-Acquired Disease Testing Market Forecast
10.3.3 Korea Hospital-Acquired Disease Testing Market Forecast
10.3.4 Southeast Asia Hospital-Acquired Disease Testing Market Forecast
10.3.5 India Hospital-Acquired Disease Testing Market Forecast
10.3.6 Australia Hospital-Acquired Disease Testing Market Forecast
10.4 Europe Hospital-Acquired Disease Testing Forecast by Country (2025-2030)
10.4.1 Germany Hospital-Acquired Disease Testing Market Forecast
10.4.2 France Hospital-Acquired Disease Testing Market Forecast
10.4.3 UK Hospital-Acquired Disease Testing Market Forecast
10.4.4 Italy Hospital-Acquired Disease Testing Market Forecast
10.4.5 Russia Hospital-Acquired Disease Testing Market Forecast
10.5 Middle East & Africa Hospital-Acquired Disease Testing Forecast by Region (2025-2030)
10.5.1 Egypt Hospital-Acquired Disease Testing Market Forecast
10.5.2 South Africa Hospital-Acquired Disease Testing Market Forecast
10.5.3 Israel Hospital-Acquired Disease Testing Market Forecast
10.5.4 Turkey Hospital-Acquired Disease Testing Market Forecast
10.5.5 GCC Countries Hospital-Acquired Disease Testing Market Forecast
10.6 Global Hospital-Acquired Disease Testing Forecast by Type (2025-2030)
10.7 Global Hospital-Acquired Disease Testing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Diatherix Laboratories
11.1.1 Diatherix Laboratories Company Information
11.1.2 Diatherix Laboratories Hospital-Acquired Disease Testing Product Offered
11.1.3 Diatherix Laboratories Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Diatherix Laboratories Main Business Overview
11.1.5 Diatherix Laboratories Latest Developments
11.2 Gen-Probe
11.2.1 Gen-Probe Company Information
11.2.2 Gen-Probe Hospital-Acquired Disease Testing Product Offered
11.2.3 Gen-Probe Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Gen-Probe Main Business Overview
11.2.5 Gen-Probe Latest Developments
11.3 Qiagen
11.3.1 Qiagen Company Information
11.3.2 Qiagen Hospital-Acquired Disease Testing Product Offered
11.3.3 Qiagen Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Qiagen Main Business Overview
11.3.5 Qiagen Latest Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Information
11.4.2 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Offered
11.4.3 F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 F. Hoffmann-La Roche Main Business Overview
11.4.5 F. Hoffmann-La Roche Latest Developments
11.5 Cepheid
11.5.1 Cepheid Company Information
11.5.2 Cepheid Hospital-Acquired Disease Testing Product Offered
11.5.3 Cepheid Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Cepheid Main Business Overview
11.5.5 Cepheid Latest Developments
11.6 Life Technologies Corporation
11.6.1 Life Technologies Corporation Company Information
11.6.2 Life Technologies Corporation Hospital-Acquired Disease Testing Product Offered
11.6.3 Life Technologies Corporation Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Life Technologies Corporation Main Business Overview
11.6.5 Life Technologies Corporation Latest Developments
11.7 Meridian Biosciences
11.7.1 Meridian Biosciences Company Information
11.7.2 Meridian Biosciences Hospital-Acquired Disease Testing Product Offered
11.7.3 Meridian Biosciences Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Meridian Biosciences Main Business Overview
11.7.5 Meridian Biosciences Latest Developments
11.8 Cantel Medical Corporation
11.8.1 Cantel Medical Corporation Company Information
11.8.2 Cantel Medical Corporation Hospital-Acquired Disease Testing Product Offered
11.8.3 Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Cantel Medical Corporation Main Business Overview
11.8.5 Cantel Medical Corporation Latest Developments
11.9 Nordion
11.9.1 Nordion Company Information
11.9.2 Nordion Hospital-Acquired Disease Testing Product Offered
11.9.3 Nordion Hospital-Acquired Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Nordion Main Business Overview
11.9.5 Nordion Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hospital-Acquired Disease Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of UTI Testing
Table 3. Major Players of SSI Testing
Table 4. Major Players of Pneumococcal Infections Testing
Table 5. Major Players of Bloodstream Infections Testing
Table 6. Major Players of MRSA Testing
Table 7. Hospital-Acquired Disease Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Hospital-Acquired Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Table 10. Hospital-Acquired Disease Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Hospital-Acquired Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Table 13. Global Hospital-Acquired Disease Testing Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Hospital-Acquired Disease Testing Revenue Market Share by Player (2019-2024)
Table 15. Hospital-Acquired Disease Testing Key Players Head office and Products Offered
Table 16. Hospital-Acquired Disease Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Hospital-Acquired Disease Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Hospital-Acquired Disease Testing Market Size Market Share by Regions (2019-2024)
Table 21. Global Hospital-Acquired Disease Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Hospital-Acquired Disease Testing Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Hospital-Acquired Disease Testing Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Hospital-Acquired Disease Testing Market Size Market Share by Country (2019-2024)
Table 25. Americas Hospital-Acquired Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Table 27. Americas Hospital-Acquired Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Table 29. APAC Hospital-Acquired Disease Testing Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Hospital-Acquired Disease Testing Market Size Market Share by Region (2019-2024)
Table 31. APAC Hospital-Acquired Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Table 33. APAC Hospital-Acquired Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Table 35. Europe Hospital-Acquired Disease Testing Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Hospital-Acquired Disease Testing Market Size Market Share by Country (2019-2024)
Table 37. Europe Hospital-Acquired Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Table 39. Europe Hospital-Acquired Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Hospital-Acquired Disease Testing Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Hospital-Acquired Disease Testing
Table 48. Key Market Challenges & Risks of Hospital-Acquired Disease Testing
Table 49. Key Industry Trends of Hospital-Acquired Disease Testing
Table 50. Global Hospital-Acquired Disease Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Hospital-Acquired Disease Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Hospital-Acquired Disease Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Hospital-Acquired Disease Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Diatherix Laboratories Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 55. Diatherix Laboratories Hospital-Acquired Disease Testing Product Offered
Table 56. Diatherix Laboratories Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Diatherix Laboratories Main Business
Table 58. Diatherix Laboratories Latest Developments
Table 59. Gen-Probe Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 60. Gen-Probe Hospital-Acquired Disease Testing Product Offered
Table 61. Gen-Probe Main Business
Table 62. Gen-Probe Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Gen-Probe Latest Developments
Table 64. Qiagen Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 65. Qiagen Hospital-Acquired Disease Testing Product Offered
Table 66. Qiagen Main Business
Table 67. Qiagen Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Qiagen Latest Developments
Table 69. F. Hoffmann-La Roche Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 70. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Offered
Table 71. F. Hoffmann-La Roche Main Business
Table 72. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. F. Hoffmann-La Roche Latest Developments
Table 74. Cepheid Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 75. Cepheid Hospital-Acquired Disease Testing Product Offered
Table 76. Cepheid Main Business
Table 77. Cepheid Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Cepheid Latest Developments
Table 79. Life Technologies Corporation Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 80. Life Technologies Corporation Hospital-Acquired Disease Testing Product Offered
Table 81. Life Technologies Corporation Main Business
Table 82. Life Technologies Corporation Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Life Technologies Corporation Latest Developments
Table 84. Meridian Biosciences Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 85. Meridian Biosciences Hospital-Acquired Disease Testing Product Offered
Table 86. Meridian Biosciences Main Business
Table 87. Meridian Biosciences Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Meridian Biosciences Latest Developments
Table 89. Cantel Medical Corporation Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 90. Cantel Medical Corporation Hospital-Acquired Disease Testing Product Offered
Table 91. Cantel Medical Corporation Main Business
Table 92. Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Cantel Medical Corporation Latest Developments
Table 94. Nordion Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 95. Nordion Hospital-Acquired Disease Testing Product Offered
Table 96. Nordion Main Business
Table 97. Nordion Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Nordion Latest Developments
Table 1. Hospital-Acquired Disease Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of UTI Testing
Table 3. Major Players of SSI Testing
Table 4. Major Players of Pneumococcal Infections Testing
Table 5. Major Players of Bloodstream Infections Testing
Table 6. Major Players of MRSA Testing
Table 7. Hospital-Acquired Disease Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Hospital-Acquired Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Table 10. Hospital-Acquired Disease Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Hospital-Acquired Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Table 13. Global Hospital-Acquired Disease Testing Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Hospital-Acquired Disease Testing Revenue Market Share by Player (2019-2024)
Table 15. Hospital-Acquired Disease Testing Key Players Head office and Products Offered
Table 16. Hospital-Acquired Disease Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Hospital-Acquired Disease Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Hospital-Acquired Disease Testing Market Size Market Share by Regions (2019-2024)
Table 21. Global Hospital-Acquired Disease Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Hospital-Acquired Disease Testing Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Hospital-Acquired Disease Testing Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Hospital-Acquired Disease Testing Market Size Market Share by Country (2019-2024)
Table 25. Americas Hospital-Acquired Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Table 27. Americas Hospital-Acquired Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Table 29. APAC Hospital-Acquired Disease Testing Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Hospital-Acquired Disease Testing Market Size Market Share by Region (2019-2024)
Table 31. APAC Hospital-Acquired Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Table 33. APAC Hospital-Acquired Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Table 35. Europe Hospital-Acquired Disease Testing Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Hospital-Acquired Disease Testing Market Size Market Share by Country (2019-2024)
Table 37. Europe Hospital-Acquired Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Table 39. Europe Hospital-Acquired Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Hospital-Acquired Disease Testing Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Hospital-Acquired Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Hospital-Acquired Disease Testing
Table 48. Key Market Challenges & Risks of Hospital-Acquired Disease Testing
Table 49. Key Industry Trends of Hospital-Acquired Disease Testing
Table 50. Global Hospital-Acquired Disease Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Hospital-Acquired Disease Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Hospital-Acquired Disease Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Hospital-Acquired Disease Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Diatherix Laboratories Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 55. Diatherix Laboratories Hospital-Acquired Disease Testing Product Offered
Table 56. Diatherix Laboratories Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Diatherix Laboratories Main Business
Table 58. Diatherix Laboratories Latest Developments
Table 59. Gen-Probe Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 60. Gen-Probe Hospital-Acquired Disease Testing Product Offered
Table 61. Gen-Probe Main Business
Table 62. Gen-Probe Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Gen-Probe Latest Developments
Table 64. Qiagen Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 65. Qiagen Hospital-Acquired Disease Testing Product Offered
Table 66. Qiagen Main Business
Table 67. Qiagen Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Qiagen Latest Developments
Table 69. F. Hoffmann-La Roche Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 70. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Product Offered
Table 71. F. Hoffmann-La Roche Main Business
Table 72. F. Hoffmann-La Roche Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. F. Hoffmann-La Roche Latest Developments
Table 74. Cepheid Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 75. Cepheid Hospital-Acquired Disease Testing Product Offered
Table 76. Cepheid Main Business
Table 77. Cepheid Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Cepheid Latest Developments
Table 79. Life Technologies Corporation Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 80. Life Technologies Corporation Hospital-Acquired Disease Testing Product Offered
Table 81. Life Technologies Corporation Main Business
Table 82. Life Technologies Corporation Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Life Technologies Corporation Latest Developments
Table 84. Meridian Biosciences Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 85. Meridian Biosciences Hospital-Acquired Disease Testing Product Offered
Table 86. Meridian Biosciences Main Business
Table 87. Meridian Biosciences Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Meridian Biosciences Latest Developments
Table 89. Cantel Medical Corporation Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 90. Cantel Medical Corporation Hospital-Acquired Disease Testing Product Offered
Table 91. Cantel Medical Corporation Main Business
Table 92. Cantel Medical Corporation Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Cantel Medical Corporation Latest Developments
Table 94. Nordion Details, Company Type, Hospital-Acquired Disease Testing Area Served and Its Competitors
Table 95. Nordion Hospital-Acquired Disease Testing Product Offered
Table 96. Nordion Main Business
Table 97. Nordion Hospital-Acquired Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Nordion Latest Developments
LIST OF FIGURES
Figure 1. Hospital-Acquired Disease Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hospital-Acquired Disease Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Hospital-Acquired Disease Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Hospital-Acquired Disease Testing Sales Market Share by Country/Region (2023)
Figure 8. Hospital-Acquired Disease Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Hospital-Acquired Disease Testing Market Size Market Share by Type in 2023
Figure 10. Hospital-Acquired Disease Testing in Small and Medium Sized Hospitals
Figure 11. Global Hospital-Acquired Disease Testing Market: Small and Medium Sized Hospitals (2019-2024) & ($ Millions)
Figure 12. Hospital-Acquired Disease Testing in Large Sized Hospitals
Figure 13. Global Hospital-Acquired Disease Testing Market: Large Sized Hospitals (2019-2024) & ($ Millions)
Figure 14. Global Hospital-Acquired Disease Testing Market Size Market Share by Application in 2023
Figure 15. Global Hospital-Acquired Disease Testing Revenue Market Share by Player in 2023
Figure 16. Global Hospital-Acquired Disease Testing Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Hospital-Acquired Disease Testing Market Size 2019-2024 ($ Millions)
Figure 18. APAC Hospital-Acquired Disease Testing Market Size 2019-2024 ($ Millions)
Figure 19. Europe Hospital-Acquired Disease Testing Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Hospital-Acquired Disease Testing Market Size 2019-2024 ($ Millions)
Figure 21. Americas Hospital-Acquired Disease Testing Value Market Share by Country in 2023
Figure 22. United States Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Hospital-Acquired Disease Testing Market Size Market Share by Region in 2023
Figure 27. APAC Hospital-Acquired Disease Testing Market Size Market Share by Type in 2023
Figure 28. APAC Hospital-Acquired Disease Testing Market Size Market Share by Application in 2023
Figure 29. China Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Hospital-Acquired Disease Testing Market Size Market Share by Country in 2023
Figure 36. Europe Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Figure 37. Europe Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Figure 38. Germany Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Hospital-Acquired Disease Testing Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 52. APAC Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 53. Europe Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 55. United States Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 56. Canada Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 59. China Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 60. Japan Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 61. Korea Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 63. India Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 64. Australia Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 65. Germany Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 66. France Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 67. UK Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 68. Italy Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 69. Russia Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 70. Spain Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 73. Israel Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 76. Global Hospital-Acquired Disease Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Hospital-Acquired Disease Testing Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Hospital-Acquired Disease Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hospital-Acquired Disease Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Hospital-Acquired Disease Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Hospital-Acquired Disease Testing Sales Market Share by Country/Region (2023)
Figure 8. Hospital-Acquired Disease Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Hospital-Acquired Disease Testing Market Size Market Share by Type in 2023
Figure 10. Hospital-Acquired Disease Testing in Small and Medium Sized Hospitals
Figure 11. Global Hospital-Acquired Disease Testing Market: Small and Medium Sized Hospitals (2019-2024) & ($ Millions)
Figure 12. Hospital-Acquired Disease Testing in Large Sized Hospitals
Figure 13. Global Hospital-Acquired Disease Testing Market: Large Sized Hospitals (2019-2024) & ($ Millions)
Figure 14. Global Hospital-Acquired Disease Testing Market Size Market Share by Application in 2023
Figure 15. Global Hospital-Acquired Disease Testing Revenue Market Share by Player in 2023
Figure 16. Global Hospital-Acquired Disease Testing Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Hospital-Acquired Disease Testing Market Size 2019-2024 ($ Millions)
Figure 18. APAC Hospital-Acquired Disease Testing Market Size 2019-2024 ($ Millions)
Figure 19. Europe Hospital-Acquired Disease Testing Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Hospital-Acquired Disease Testing Market Size 2019-2024 ($ Millions)
Figure 21. Americas Hospital-Acquired Disease Testing Value Market Share by Country in 2023
Figure 22. United States Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Hospital-Acquired Disease Testing Market Size Market Share by Region in 2023
Figure 27. APAC Hospital-Acquired Disease Testing Market Size Market Share by Type in 2023
Figure 28. APAC Hospital-Acquired Disease Testing Market Size Market Share by Application in 2023
Figure 29. China Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Hospital-Acquired Disease Testing Market Size Market Share by Country in 2023
Figure 36. Europe Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Figure 37. Europe Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Figure 38. Germany Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Hospital-Acquired Disease Testing Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Hospital-Acquired Disease Testing Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Hospital-Acquired Disease Testing Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Hospital-Acquired Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 52. APAC Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 53. Europe Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 55. United States Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 56. Canada Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 59. China Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 60. Japan Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 61. Korea Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 63. India Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 64. Australia Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 65. Germany Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 66. France Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 67. UK Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 68. Italy Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 69. Russia Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 70. Spain Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 73. Israel Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Hospital-Acquired Disease Testing Market Size 2025-2030 ($ Millions)
Figure 76. Global Hospital-Acquired Disease Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Hospital-Acquired Disease Testing Market Size Market Share Forecast by Application (2025-2030)
